diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)

Minneapolis Heart Institute Foundation

Status: Completed

Conditions: Diabetes Mellitus, Type 2

Treatments: Behavioral: Coaching

Study type: Interventional

Funder types: Other

Identifiers

NCT02980978

ENHANCED

Details and patient eligibility

About

This study aims to randomly assign individuals with type 2 diabetes into the ENHANCED randomized control trial. The study is being conducted by the Minneapolis Heart Institute Foundation (MHIF) and will have two study sites 1) Hutchinson Health and 2) New Ulm Medical Center. The study is primarily funded through the Academy of Nutrition and Dietetics (AND).

The study will examine the impact of a registered dietitian-led, primary care integrated, telemedicine program on diabetes care measures (the 'D5') over one year as compared to usual care. The D5 goals include: blood pressure <140/90 mmHg, taking a statin as appropriate, A1c <8%, not using tobacco and taking an aspirin as appropriate.

Full description

Individuals will be invited to attend a baseline visit where they will have lab work done, anthropometrics (height, weight, waist circumference) and complete a lifestyle assessment. They will formally consent to participation by signing a study consent form. The same measures will be collected after completion of the one year study.

Study participants will receive two sessions of free lab work, a diabetes education book, and brief coaching with a registered dietitian/certified diabetes educator. In addition, those randomized to the phone coaching will have access to a registered dietitian/certified diabetes educator on a monthly basis for one year of personalized health coaching for free. The intent of this coaching is to help individuals achieve diabetes "optimal" care or meeting all 5 Diabetes Care measures (blood glucose, blood pressure, tobacco use, statin and aspirin use).

This program is designed to complement usual clinic-based primary care, with coaches documenting lab, biometrics and medication adjustments in the EHR, along with documenting phone encounters and communicating directly with patients' PCPs as needed. Documentation in the EHR uses an order created specifically for the study indicating the patient's research status.

Lab work required as part of this research study at baseline and 12 months is covered by the study. Any lab work and/or medication co-pays or fees outside of the baseline and 12 month study visits are the responsibility of the patient and/or their insurance

Enrollment: 118 patients

Sex: All

Ages: 40 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Diagnosis of Type 2 Diabetes
2. Individuals who are not meeting 3 or more D5 goals,
3. Have had a visit with a provider within the last 2 years

Exclusion criteria

1. Type 1 Diabetes
2. Chronic kidney disease (GFR <30)
3. HIV
4. Institutional residence
5. Major cognitive or language barrier (as determined by program enrollment staff)
6. Other active end-stage disease (e.g., late stage cancer or pulmonary disease)
7. Actively receiving cancer treatment
8. Pregnant

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

118 participants in 2 patient groups

Intervention

Experimental group

Description:

Individuals assigned to the intervention group will have supplemental care provided by a registered dietitian/certified diabetes educator which includes counseling on lifestyle to improve diabetes and overall health. Additionally, individuals in this group may be started on medications (or adjustments to current medications) for blood pressure, cholesterol or blood glucose to meet diabetes care goals

Treatment:

Behavioral: Coaching

Standard of Care

No Intervention group

Description:

Individuals will be followed by their Primary Care Provider as standard of care and per usual clinical need